SCHEMBL9530979

SCHEMBL9530979

CCOc1nc(CC)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 9/20 0.41
AGTR2 P50052 9/20 0.41
ABCB11 O95342 1/20 0.35
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
CYP3A4 P08684 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CYP2C9 P11712 1/20 0.35
ADRB3 P13945 1/20 0.35
ADRA2B P18089 1/20 0.35
SLC6A2 P23975 1/20 0.35
TBXAS1 P24557 1/20 0.35
HTR2C P28335 1/20 0.35
PPARG P37231 1/20 0.35
HTR2B P41595 1/20 0.35
PDE3A Q14432 1/20 0.35
LTB4R2 Q9NPC1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529351 0.92 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9528786 0.92 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9529940 0.91 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9531830 0.91 AGTR1 (0.42) AGTR1AGTR2ABCB11EGFRERBB2
SCHEMBL9528566 0.91 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9529861 0.90 AGTR1 (0.38) AGTR1AGTR2ABCB11EGFRERBB2
SCHEMBL9527484 0.90 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL9528306 0.89 AGTR1 (0.38) AGTR1AGTR2ABCB11EGFRERBB2
SCHEMBL9529701 0.89 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9528298 0.89 AGTR1 (0.38) AGTR1AGTR2ABCB11EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed